Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004159486 | SCV003654755 | uncertain significance | not specified | 2022-10-04 | criteria provided, single submitter | clinical testing | The c.1688A>G (p.D563G) alteration is located in exon 4 (coding exon 4) of the NPC1L1 gene. This alteration results from a A to G substitution at nucleotide position 1688, causing the aspartic acid (D) at amino acid position 563 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |